MassBio held its two-day 2016 annual meeting on March 31-April 1, and has posted a thorough recap of the event.
“More than 450 professionals in the life sciences industry joined MassBio at the 2016 Annual Meeting, featuring keynote addresses from High School Honors Student, Athlete and CF Advocate Kate Marshall and Dr. Tony Coles, Chairman & CEO of Yumanity Therapeutics.
At this year’s meeting, biotech executives, regulators, entrepreneurs and funders all came together to discuss hot topics affecting the industry. Conversations covered subjects such as price & value, advanced manufacturing, digital healthcare and more over a two-day period.
The Annual Meeting began with opening remarks from Bob Coughlin, President & CEO of MassBio. Bob addressed the need for industry professionals to lead the public discussion on debated issues affecting life sciences, saying “it’s time for us to start getting loud– what we do saves lives.” Bob also thanked outgoing Chairman of the Board, Glenn Batchelder, for his service and dedication to the MassBio community.”